Quality and documentation are important considerations throughout the pharmaceutical sector. IFT Life Sciences recognises the role of applicable regulatory requirements, accurate product information and appropriate quality systems. Company-specific certifications and capabilities should be verified against current documents.
Pharmaceutical quality depends on robust systems, trained personnel, appropriate facilities, validated processes, testing and ongoing oversight. IFT Life Sciences recognises the importance of these elements across the pharmaceutical supply chain.
Specific certifications, manufacturing site details, testing capabilities and regulatory approvals should be confirmed against current documentation for the relevant product and facility.
Request company informationProducts and operations must comply with applicable laws, regulations and approved documentation.
Testing and quality-control requirements should be defined by the relevant product specifications and applicable standards.
Accurate product, batch and regulatory documentation supports traceability and responsible communication.
Documentation, appropriate testing and regulatory alignment are important considerations in pharmaceutical operations.
Illustrative imagery only. Confirm any company-specific quality or certification statements with current documentation.
Accurate product particulars, current approved labelling and traceable documentation are important when communicating about pharmaceutical formulations. Information should be checked against documents applicable to the specific product and market.
References to GMP status, manufacturing sites, quality-control laboratories, testing capabilities or regulatory approvals should only be made when current documentary evidence is available.